ASX - By Stock
|
IIQ |
Re:
Ann: Ovarian Cancer Test Validation
|
|
Builderjosh
|
59 |
17K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
59
|
17K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Screening v monitoring
|
|
Builderjosh
|
11 |
3.1K |
2 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
11
|
3.1K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: 2023 AGM CEO Presentation
|
|
Builderjosh
|
5 |
1.8K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
5
|
1.8K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
Builderjosh
|
217 |
112K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
217
|
112K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C and Quarterly Activities Report - September 2023
|
|
Builderjosh
|
4 |
1.5K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
4
|
1.5K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive EXO-NET Results in Ovarian Cancer
|
|
Builderjosh
|
33 |
13K |
8 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
33
|
13K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Positive SubB2M IHC Results for Melanoma
|
|
Builderjosh
|
8 |
4.4K |
13 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
8
|
4.4K
|
13
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: hTERT US Patent Granted
|
|
Builderjosh
|
10 |
5.0K |
9 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
10
|
5.0K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
|
|
Builderjosh
|
9 |
3.8K |
9 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
9
|
3.8K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Awarded Additional BTB Funding to Develop SubB2M test
|
|
Builderjosh
|
21 |
10K |
15 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
21
|
10K
|
15
|
|